Citius Pharmaceuticals, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Citius Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $34.00.
- Citius Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $31.27K.
- Citius Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $82.63K.
- Citius Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-12-31 was $500.00.
- Citius Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $31.27K.
- Citius Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $82.63K.
- Citius Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $40.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $34.00 10-Q · filed 2026-08-14 | |
| 2023-09-30 | $31.27K 10-K · filed 2024-12-27 | |
| 2023-03-31 | $31.27K 10-Q · filed 2024-08-12 | |
| 2021-09-30 | $82.63K 10-K · filed 2022-12-22 | |
| 2021-06-30 | $82.63K 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $500.00 10-Q · filed 2022-05-12 | |
| 2017-09-30 | $40.00 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |